Login Register Cart 0
Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Heterocyclic Compounds Bearing Triazine Scaffold and Their Biological Significance: A Review

Author(s): Tarawanti Verma, Manish Sinha and Nitin Bansal*

Volume 20, Issue 1, 2020

Page: [4 - 28] Pages: 25

DOI: 10.2174/1871520619666191028111351

Price: $65

Abstract

Benzene is a six-membered hydrocarbon ring system and if three carbon-hydrogen units of benzene ring are replaced by nitrogen atoms then triazine is formed. Triazines are present in three isomeric forms 1,2,3- triazine, 1,2,4-triazine, and 1,3,5-triazine according to the position of the nitrogen atom. These are weak bases having weaker resonance energy than benzene, so nucleophilic substitution is preferred than electrophilic substitution. Triazine is an interesting class of heterocyclic compounds in medicinal chemistry. Numerous synthetic derivatives of triazine have been prepared and evaluated for a wide spectrum of biological activities in different models with desired findings such as antibacterial, antifungal, anti-cancer, antiviral, antimalarial, antiinflammatory, antiulcer, anticonvulsant, antimicrobial, insecticidal and herbicidal agents. Triazine analogs have exposed potent pharmacological activity. So, triazine nucleus may be considered as an interesting core moiety for researchers for the development of future drugs.

Keywords: Triazine, anti-cancer, antimicrobial, antimalarial, anticonvulsant, heterocyclic compounds.

« Previous Next »
Graphical Abstract

[1]
Nikalje, A.P.; Pattan, S.; Mane, A. Microwave-assisted solvent free synthesis and biological evaluation of 2-(4-arylthiazol-2-yl-amino)-N-aryl acetamides. Asian J. Exp. Biol. Sci., 2010, 1(2), 344-351.
[2]
Argade, N.D.; Kalrale, B.K.; Gill, C.H. Microwave assisted improved method for the synthesis of pyrazole containing 2,4-disubstituted oxazole-5-one and their antimicrobial activity. e-. J. Chem., 2008, 5(1), 120-129.
[3]
Gahtori, P.; Singh, B.K.; Das, A. Synthesis of phenyl-1,3-thiazole substituted amino s-triazines as antibacterial agents. J. Pharm. Sci., 2008, 7(2), 107-111.
[4]
Srinivas, K.; Srinivas, U.; Bhanuprakash, K.; Harakishore, K.; Murthy, U.S.; Rao, V.J. Synthesis and antibacterial activity of various substituted s-triazines. Eur. J. Med. Chem., 2006, 41(11), 1240-1246.
[http://dx.doi.org/10.1016/j.ejmech.2006.05.013] [PMID: 16815597]
[5]
Blotny, G. Recent applications of 2,4,6-trichloro-1,3,5-triazine and its derivatives in organic synthesis. Tetrahedron, 2006, 62, 9507-9522.
[http://dx.doi.org/10.1016/j.tet.2006.07.039]
[6]
McKay, G.A.; Reddy, R.; Arhin, F.; Belley, A.; Lehoux, D.; Moeck, G.; Sarmiento, I.; Parr, T.R.; Gros, P.; Pelletier, J.; Far, A.R. Triaminotriazine DNA helicase inhibitors with antibacterial activity. Bioorg. Med. Chem. Lett., 2006, 16(5), 1286-1290.
[http://dx.doi.org/10.1016/j.bmcl.2005.11.076] [PMID: 16343901]
[7]
Nishigaki, S.; Yoneda, F.; Matsumoto, H.; Morinaga, K. Synthetic antibacterials. I. Nitrofurylvinyl-s-triazine derivatives. J. Med. Chem., 1969, 12(1), 39-42.
[http://dx.doi.org/10.1021/jm00301a010] [PMID: 4973987]
[8]
Saleh, M.; Abbott, S.; Perron, V.; Lauzon, C.; Penney, C.; Zacharie, B. Synthesis and antimicrobial activity of 2-fluorophenyl-4,6-disubstituted [1,3,5]triazines. Bioorg. Med. Chem. Lett., 2010, 20(3), 945-949.
[http://dx.doi.org/10.1016/j.bmcl.2009.12.063] [PMID: 20053565]
[9]
Saravanan, J.; Mohan, S.; Roy, J.J. Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents. Eur. J. Med. Chem., 2010, 45(9), 4365-4369.
[http://dx.doi.org/10.1016/j.ejmech.2010.05.061] [PMID: 20579782]
[10]
Kidwai, M.; Goel, Y.; Kumar, R. Microwave assisted synthesis and antifungal activity of 1, 2, 4-triazine, 1, 2, 4-triazole, tetrazole and pyrazole derivatives. Indian J. Chem., 1998, 37B(2), 174-179.
[http://dx.doi.org/10.1002/chin.199840047]
[11]
Holla, B.S.; Gonsalves, R.; Rao, B.S.; Shenoy, S.; Gopalakrishna, H.N. Synthesis of some new biologically active bis-(thiadiazolotriazines) and bis-(thiadiazolotriazinyl) alkanes. Farmaco, 2001, 56(12), 899-903.
[http://dx.doi.org/10.1016/S0014-827X(01)01119-3] [PMID: 11829109]
[12]
Kamchonwongpaisan, S.; Quarrell, R.; Charoensetakul, N.; Ponsinet, R.; Vilaivan, T.; Vanichtanankul, J.; Tarnchompoo, B.; Sirawaraporn, W.; Lowe, G.; Yuthavong, Y. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities. J. Med. Chem., 2004, 47(3), 673-680.
[http://dx.doi.org/10.1021/jm030165t] [PMID: 14736247]
[13]
Falke, D.; Rada, B. 6-Azauridine as an inhibitor of the synthesis of Herpesvirus hominis. Acta Virol., 1970, 14(2), 115-123.
[PMID: 4192445]
[14]
Abdel-Rahman, R.M.; Seada, M.; Fawzy, M.; el-Baz, I. Synthesis of some new 1,6-dihydro-3-substituted 6-spiro-(9′-fluorene)-1,2,4-triazin-5-(4H)-ones as potential anti HIV and anticancer drugs. Pharmazie, 1994, 49(10), 729-733.
[PMID: 7816899]
[15]
Sidwell, R.W.; Dixon, G.J.; Sellers, S.M.; Schabel, F.M., Jr In vivo antiviral properties of biologically active compounds. II. Studies with influenza and vaccinia viruses. Appl. Microbiol., 1968, 16(2), 370-392.
[PMID: 5694419]
[16]
Pandey, V.K.; Tusi, S.; Tusi, Z.; Joshi, M.; Bajpai, S. Synthesis and biological activity of substituted 2,4,6-s-triazines. Acta Pharm., 2004, 54(1), 1-12.
[PMID: 15050040]
[17]
Roth, B.; Burrows, R.B.; Hitchings, G.H. Anthelmintic agents: 1,2-dihydro-s-triazines. J. Med. Chem., 1963, 6, 370-378.
[http://dx.doi.org/10.1021/jm00340a008] [PMID: 14184889]
[18]
Garuti, L.; Roberti, M.; Rossi, T.; Castelli, M.; Malagoli, M. Synthesis and antiproliferative activity of I)-substituted lH-indole [3,2-d&1,2,3-triazin-4 (3H)-ones. Eur. J. Med. Chem., 1998, 33, 43-46.
[http://dx.doi.org/10.1016/S0223-5234(99)80074-9]
[19]
Smith, R.H., Jr; Scudiero, D.A.; Michejda, C.J. 1,3-Dialkyl-3-acyltriazenes, a novel class of antineoplastic alkylating agents. J. Med. Chem., 1990, 33(9), 2579-2583.
[http://dx.doi.org/10.1021/jm00171a036] [PMID: 2391696]
[20]
Sztanke, K.; Rzymowska, J.; Niemczyk, M.; Dybała, I.; Kozioł, A.E. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate. Eur. J. Med. Chem., 2006, 41(4), 539-547.
[http://dx.doi.org/10.1016/j.ejmech.2006.01.016] [PMID: 16545495]
[21]
Sztanke, K.; Pasternak, K.; Sztanke, M.; Kandefer-Szerszeń, M.; Kozioł, A.E.; Dybała, I. Crystal structure, antitumour and antimetastatic activities of disubstituted fused 1,2,4-triazinones. Bioorg. Med. Chem. Lett., 2009, 19(17), 5095-5100.
[http://dx.doi.org/10.1016/j.bmcl.2009.07.036] [PMID: 19631534]
[22]
Mallikarjuna, B.P.; Suresh Kumar, G.V.; Sastry, B.S.; Nagaraj, K.P.; Manohara, K.P. Synthesis and anticonvulsant activity of some potent 5,6-bis aryl 1,2,4-triazines. J. Zhejiang Univ. Sci. B, 2007, 8(7), 526-532.
[http://dx.doi.org/10.1631/jzus.2007.B0526] [PMID: 17674488]
[23]
Lesieur; Aichaw, H. Eur. Pat., 390 673/1990. Chem. Abstr., 1991, 114, 143.
[24]
Bonsignore, L.; Loy, G.; Secci, D.; Calignano, A. Synthesis and pharmacological activity of 2-oxo-(2H)-1-benzopyran-3-carboxamide derivatives. Eur. J. Med. Chem., 1993, 28(6), 517-520.
[http://dx.doi.org/10.1016/0223-5234(93)90020-F]
[25]
Mullick, P.; Khan, S.A.; Begum, T.; Verma, S.; Kaushik, D.; Alam, O. Synthesis of 1,2,4-triazine derivatives as potential anti-anxiety and anti-inflammatory agents. Acta Pol. Pharm., 2009, 66(4), 379-385.
[PMID: 19702169]
[26]
Finar, I.L. Organic Chemistry: Stereochemistry and the chemistry of natural products, 5th ed; Dorling Kindersley: India, 2006, Vol. 2, pp. 650-651.
[27]
Hua, Z.; Jihong, L.; Qiang, X. Synthesis and characterization of novel derivatives of triazinone. Front. Chem. China, 2007, 2(2), 164-168.
[http://dx.doi.org/10.1007/s11458-007-0033-5]
[28]
Abdel-Rahman, R.M. Synthesis of some new 3-thioxo-1,2,4-triazinone derivatives. Pak. J. Sci. Ind. Res., 1987, 30, 490-495.
[29]
Abdel-Mariah, F.A.; Saad, H.A.; Allimony, H.A.; Abdel-Rahman, R.M. Synthesis and antimicrobial activity of some nitrogen heterobicyclic system: Part III. Indian J. Chem., 2000, 39B(1), 36-41.
[30]
Abdel-Rahman, R.M. Synthesis and chemistry of fluorine containing bioactive 1,2,4-triazines--an overview. Chemistry of uncondensed 1,2,4-triazines, Part III. Pharmazie, 1999, 54(11), 791-803.
[PMID: 10603605]
[31]
Abdel-Rahman, R.M. Chemistry of uncondensed 1,2,4-triazines, Part IV. Synthesis and chemistry of bioactive 3-amino-1,2,4-triazines and related compounds--an overview. Pharmazie, 2001, 56(4), 275-286.
[PMID: 11338663]
[32]
Abdel-Rahman, R.M. Role of uncondensed 1,2,4-triazine derivatives as biocidal plant protection agents--a review. Pharmazie, 2001, 56(3), 195-204.
[http://dx.doi.org/10.1002/chin.200122235] [PMID: 11265582]
[33]
Abdel-Rahman, R.M. Role of uncondensed 1,2,4-triazine compounds and related heterobicyclic systems as therapeutic agents--a review. Pharmazie, 2001, 56(1), 18-22.
[PMID: 11210661]
[34]
el-Gendy, Z.; Morsy, J.M.; Allimony, H.A.; Ali, W.R.; Abdel-Rahman, R.M. Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs, part III. Pharmazie, 2001, 56(5), 376-383.
[PMID: 11400552]
[35]
El-Gendy, Z.; Morsy, J.M.; Allimony, H.A.; Abdel-Monem, A.W.R.; Abdel-Rahman, R.M. Synthesis of heterobicyclic nitrogen systems bearing a 1,2,4-triazine moiety as anticancer drugs: Part IV. Phosphorus Sulfur Silicon Relat. Elem., 2003, 178(9), 2055-2071.
[http://dx.doi.org/10.1080/10426500390228738]
[36]
Kaushik, D.; Khan, S.A.; Chawla, G. Design & synthesis of 2-(substituted aryloxy)-5-(substituted benzylidene)-3-phenyl-2,5-dihydro-1H-[1,2,4] triazin-6-one as potential anticonvulsant agents. Eur. J. Med. Chem., 2010, 45(9), 3960-3969.
[http://dx.doi.org/10.1016/j.ejmech.2010.05.051] [PMID: 20573424]
[37]
Singh, H.; Kapoor, V.K. Medicinal and Pharmaceutical Chemistry, 2nd ed; Vallabh Prakashan: Delhi, 2007.
[38]
Tripathi, K.D. Antiepileptic Drugs In: Essentials of Medical Pharmacology.sixth ed., Jaypee Brothers Medical Publisher (P) Ltd.New Delhi,. , 2009; p. 409.
[39]
Abdel-Rahman, R.M.; Morsy, J.M.; Hanafy, F.; Amene, H.A. Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs: Part I. Pharmazie, 1999, 54(5), 347-351.
[PMID: 10368828]
[40]
Partridge, M.W.; Stevens, M.F.G. Pyrazolo-as-triazines: Part I. J. Chem. Soc. C, 1966, 1127-1131
[http://dx.doi.org/10.1039/J39660001127]
[41]
Abd el-Samii, Z.K. Synthesis and anti-inflammatory activity of some novel 1,3,4-oxadiazole derivatives. J. Chem. Technol. Biotechnol., 1992, 53(2), 143-146.
[http://dx.doi.org/10.1002/jctb.280530206] [PMID: 1368010]
[42]
Hay, M.P.; Pruijn, F.B.; Gamage, S.A.; Liyanage, H.D.; Kovacs, M.S.; Patterson, A.V.; Wilson, W.R.; Brown, J.M.; Denny, W.A. DNA-targeted 1,2,4-benzotriazine 1,4-dioxides: potent analogues of the hypoxia-selective cytotoxin tirapazamine. J. Med. Chem., 2004, 47(2), 475-488.
[http://dx.doi.org/10.1021/jm030399c] [PMID: 14711317]
[43]
Heilman, W.P.; Heilman, R.D.; Scozzie, J.A.; Wayner, R.J.; Gullo, J.M.; Ariyan, Z.S. Synthesis and antihypertensive activity of novel 3-hydrazino-5-phenyl-1,2,4-triazines. J. Med. Chem., 1979, 22(6), 671-677.
[http://dx.doi.org/10.1021/jm00192a012] [PMID: 458822]
[44]
Chaudhari, J.A.; Patel, R.P.; Hathi, M.V. Studies on novel bisaryl hydrazino-s-triazine derivatives: Part 2. e-. J. Chem., 2007, 4(3), 385-389.
[45]
Shaikh, B.M.; Chobe, S.S.; Konda, S.G.; Khandare, N.T.; Chavan, S.A.; Dawane, B.S. An efficient synthesis and in vitro antimicrobial activity of 1, 2, 4-triazin-6-(5H)-one derivatives. Der. Chemica. Sinica., 2010, 1(2), 86-91.
[46]
Dalloul, H.M.; Al-Shorafa, A.Z. On reactions of triazinones: Synthesis of new 5-arylidene-4,5-dihydro-1,2,4-triazin-6-ones. Org. Commun., 2009, 2(1), 20-27.
[47]
Dawane, B.S.; Kadam, S.N.; Shaikh, B.M. An efficient synthesis of 1, 2, 4-triazine derivatives and their in vitro antimicrobial activity. Der. Pharmacia Lett., 2010, 2(4), 126-131.
[48]
Chen, H.; Dao, P.; Laporte, A.; Garbay, C. High yielding microwave-assisted synthesis of 2-(arylmethyl)amino-4-arylamino-6-alkyl-1,3,5-triazines. Tetrahedron Lett., 2010, 51, 3174-3176.
[http://dx.doi.org/10.1016/j.tetlet.2010.04.042]
[49]
Irannejad, H.; Nadri, H.; Naderi, N.; Rezaeian, S.N.; Zafari, N.; Foroumadi, A.; Amini, M.; Khoobi, M. Anticonvulsant activity of 1,2,4-triazine derivatives with pyridyl side chain: Synthesis, biological and computational study. Med. Chem. Res., 2015, 24, 2505-2513.
[http://dx.doi.org/10.1007/s00044-014-1315-3]
[50]
Sahu, M.; Siddiqui, N.; Naim, M.J.; Alam, O.; Yar, M.S.; Sharma, V.; Wakode, S. Design, synthesis, and docking study of pyrimidine-triazine hybrids for GABA estimation in animal epilepsy models. Arch. Pharm. (Weinheim), 2017, 350(9)e1700146
[http://dx.doi.org/10.1002/ardp.201700146] [PMID: 28758238]
[51]
Amir, M.; Ali, I.; Hassan, M.Z.; Mulakayala, N. Design, synthesis, and biological evaluation of hydrazone incorporated 1,2,4-triazines as anticonvulsant agents. Arch. Pharm. (Weinheim), 2014, 347(12), 958-968.
[http://dx.doi.org/10.1002/ardp.201400045] [PMID: 25251582]
[52]
Irannejad, H.; Naderi, N.; Emami, S.; Ghadikolaei, R.Q.; Foroumadi, A.; Zafari, T.; Mazar-Atabaki, A.; Dadashpour, S. Microwave-assisted synthesis and anticonvulsant activity of 5,6-bisaryl-1,2,4-triazine-3-thiol derivatives. Med. Chem. Res., 2014, 23, 2503-2514.
[http://dx.doi.org/10.1007/s00044-013-0843-6]
[53]
Ahuja, P.; Siddiqui, N. Anticonvulsant evaluation of clubbed indole-1,2,4-triazine derivatives: A synthetic approach. Eur. J. Med. Chem., 2014, 80, 509-522.
[http://dx.doi.org/10.1016/j.ejmech.2014.04.043] [PMID: 24813879]
[54]
Khan, A.A.; Siddiqui, N.; Akhtar, M.J.; Ali, Z.; Yar, M.S. Design, synthesis, and biological evaluation of 6-(2-aminosubstituted phenyl)-4-(substituted phenyl)-1,2,4-triazine-3,5(2H,4H)-dione derivatives as anticonvulsant agents. Arch. Pharm. (Weinheim), 2016, 349(4), 277-292.
[http://dx.doi.org/10.1002/ardp.201500448] [PMID: 26996080]
[55]
Firdaus, J.U.; Habib, A.; Siddiqui, N.; Alam, O.; Naim, J.M.; Partap, S.; Sahu, M. Design, synthesis, and molecular docking study of benzothiazolotriazine derivatives for anticonvulsant potential. Arch. Pharm. Chem. Life Sci, 2018, 351(12)1800154
[http://dx.doi.org/10.1002/ardp.201800154]
[56]
Apropazone. http://en.wikipedia.org/wiki/Azapropazone 2011. Accessed: 2011 April 18.
[57]
Shinde, R.S.; Salunke, S.D. Synthesis and studies of novel piperidine-substituted triazine derivatives as potential anti-inflammatory and antimicrobial agents. J. Chem. Pharm. Res., 2015, 7(7), 704-714.
[58]
Rihong, T. Synthesis and biological activities of 1,2,4-triazine derivatives. Adv. Mat. Res., 2014, 1033-1034, 283-286.
[http://dx.doi.org/10.4028/www.scientific.net/AMR.1033-1034.283]
[59]
Khoshneviszadeh, M.; Ghahremani, M.H.; Foroumadi, A.; Miri, R.; Firuzi, O.; Madadkar-Sobhani, A.; Edraki, N.; Parsa, M.; Shafiee, A. Design, synthesis and biological evaluation of novel anti-cytokine 1,2,4-triazine derivatives. Bioorg. Med. Chem., 2013, 21(21), 6708-6717.
[http://dx.doi.org/10.1016/j.bmc.2013.08.009] [PMID: 23993677]
[60]
Makki, M.; Bakhotmah, D.A.; Abdel-Rahman, R.M.; Aqlan, F.M. New route to synthesize fluorine substituted lamotrigine drug analogues as an anti-inflammatory agent. Curr. Org. Synth., 2018, 15, 116-125.
[http://dx.doi.org/10.2174/1570179414666170509151123]
[61]
Tiwari, S.; Tiwari, N.; Agarwal, T.; Khan, M.H.; Nizamuddin, N. Synthesis of some 2-substituted- 1,3,4- thiadiazolo[2,3-c]-1,2,4-triazino-[5,6-b] indoles as fungicides. Indian J. Chem., 1995, 34B(11), 1010-1012.
[62]
Dandia, A.; Arya, K.; Sati, M.; Sarawgi, P. Green chemical synthesis of fluorinated 1, 3, 5-triaryl-s-triazines in aqueous medium under microwaves as potential antifungal agents. J. Fluor. Chem., 2004, 125(9), 1273-1277.
[http://dx.doi.org/10.1016/j.jfluchem.2004.03.002]
[63]
Jag, M. Heterocyclic systems containing bridgehead nitrogen atom: Synthesis and bioactivity of thiazolo[3′,2′:2,3] as triazino[5,6-b] indoles and isomeric thiazolo[2′,3′:3,4] as triazino[5,6-b] indoles. Indian J. Chem., 2004, 43B(7), 1585-1587.
[64]
Srinivas, K.; Srinivas, U.; Rao, V.J.; Bhanuprakash, K.; Kishore, K.H.; Murty, U.S.N. Synthesis and antibacterial activity of 2,4,6-tri substituted s-triazines. Bioorg. Med. Chem. Lett., 2005, 15(4), 1121-1123.
[http://dx.doi.org/10.1016/j.bmcl.2004.12.020] [PMID: 15686925]
[65]
Vzorov, A.N.; Bhattacharyya, D.; Marzilli, L.G.; Compans, R.W. Prevention of HIV-1 infection by platinum triazines. Antiviral Res., 2005, 65(2), 57-67.
[http://dx.doi.org/10.1016/j.antiviral.2004.06.011] [PMID: 15708632]
[66]
Mulwad, V.V.; Chaskar, A.C. Synthesis and antibacterial activity of new oxadiazolo [1,3,5]- triazine, 1,2,4 triazolo and thiadiazolo 1,3,4 oxadiazolo derivatives. Indian J. Chem., 2006, 45B(7), 1710-1715.
[http://dx.doi.org/10.1002/chin.200647149]
[67]
Sharma, C.; Sharma, S.; Hussain, N.; Talesara, G.L. Synthesis and antimicrobial activity of some new phthalimidoxy derivatives of triazine containing pyrimidine and isoxazole. J. Indian Council Chem., 2009, 26(1), 31-36.
[68]
Baldaniya, B.B.; Patel, P.K. Synthesis, antibacterial and antifungal activities of s-triazine derivatives. E-J. Chem., 2009, 6(3), 673-680.
[http://dx.doi.org/10.1155/2009/196309]
[69]
Raval, J.P.; Rai, A.R.; Patel, N.H.; Patel, H.V.; Patel, P.S. Synthesis and in vitro antimicrobial activity of N′-(4-(arylamino)-6-(pyridin-2-ylamino)-1,3,5-triazin-2-yl)benzohydrazide. Int. J. Chemtech Res., 2009, 1(3), 616-620.
[70]
Patel, D.; Toliwal, S.D.; Patel, J.V.; Jadav, K.; Gupte, A.; Patel, Y. Studies on microwave assisted synthesis of triazines from byproducts of oil processing industries. J. Appl. Chem. Res., 2011, 16, 53-60.
[71]
Tarun, M.P.; Amit, M.P. Synthesis and antimicrobial activity of newly azetidinone derivatives. Der Pharmacia Lett., 2012, 4(2), 579-583.
[72]
Singh, U.P.; Gahtori, P.; Singh, R.K. In vitro antifungal activity of some 1,3,5-triazine derivatives, Available from Nature Precedings http://hdl.handle.net/10101/npre.2011.5751.12011.
[73]
Riyadh, S.M. Enaminones as building blocks for the synthesis of substituted pyrazoles with antitumor and antimicrobial activities. Molecules, 2011, 16(2), 1834-1853.
[http://dx.doi.org/10.3390/molecules16021834] [PMID: 21343888]
[74]
Patel, R.V.; Kumari, P.; Rajani, D.P.; Chikhalia, K.H. Synthesis and studies of novel 2-(4-cyano-3-trifluoromethylphenyl amino)-4-(quinoline-4-yloxy)-6-(piperazinyl/piperidinyl)-s-triazines as potential antimicrobial, antimycobacterial and anticancer agents. Eur. J. Med. Chem., 2011, 46(9), 4354-4365.
[http://dx.doi.org/10.1016/j.ejmech.2011.07.006] [PMID: 21794959]
[75]
Zhou, Y.; Sun, Z.; Froelich, J.M.; Hermann, T.; Wall, D. Structure-activity relationships of novel antibacterial translation inhibitors: 3,5-diamino-piperidinyl triazines. Bioorg. Med. Chem. Lett., 2006, 16(20), 5451-5456.
[http://dx.doi.org/10.1016/j.bmcl.2006.07.052] [PMID: 16890435]
[76]
Deshmukh, R.; Jha, A.K.; Thakur, A.K.; Dewangan, D. Synthesis and antibacterial activity of some 1, 3, 4-oxadiazole derivatives and their thione analogues. Int. J. Res. Pharm. Biomed. Sci., 2011, 2(1), 215-219.
[77]
Narsibhai, B.D.K.; Mishra, D.; Vyavahare, L.V.; Singh, A. Synthesis, characterization and antimicrobial activity of novel heterocyclic compounds. J. Curr. Chem. Pharm. Sci., 2012, 2(4), 233-239.
[78]
Elsilk, S.E.; El-barbary, A.A. Antimicrobial activity studies on 1,2,4-triazine derivative in vitro. Mid-East J. Sci. Res., 2010, 6(1), 31-36.
[79]
Singh, K.; Raparia, S.; Raparia, S. Synthesis, characterization and biological evaluation of triazine based schiff base metal complexes. Eur. Chem. Bull., 2016, 5(3), 92-98.
[80]
Al-Zaydi, K.M.; Khalil, H.H.; El-Faham, A.; Khattab, S.N. Synthesis, characterization and evaluation of 1,3,5-triazine aminobenzoic acid derivatives for their antimicrobial activity. Chem. Cent. J., 2017, 11(1), 39.
[http://dx.doi.org/10.1186/s13065-017-0267-3] [PMID: 29086830]
[81]
Sarmah, K.N.; Patel, T.V. Synthesis, characterization, antimicrobial studies of certain s-triazine derived compounds and analogues. Arch. Appl. Sci. Res., 2011, 3(6), 428-436.
[82]
Mishra, K. Synthesis and biological evaluation of 2-aryl - 6, 7-difluorophenyl-1,3,4- oxadiazolo (3,2-a) (1,3,5)-triazine-5-(6H,7H)-thiones. Chem. Sci. J., 2017, 8(2), 1-3.
[http://dx.doi.org/10.4172/2150-3494.1000153]
[83]
Dongre, R.P.; Rathod, S.D. Synthesis of novel isoxazoline derivatives containing s-triazine via chalcones and their anti-microbial studies. Pharma Chem., 2017, 9(7), 68-71.
[84]
Al-Adiwish, W.M.; Abubakr, M.A.S.; Alarafi, N.M. synthesis of new pyrazolo [5, 1-c 1, 2, 4] triazines from 5-aminopyrazole and study biological activity and cytotoxicity. Int. J. Photochem. Photobiol., 2017, 2(2), 41-48.
[http://dx.doi.org/10.11648/j.cb.20170505.11]
[85]
Desai, N.C.; Makwana, A.H.; Senta, R.D. Synthesis, characterization and antimicrobial activity of some new 4-(4-(2-isonicotinoylhydrazinyl)-6-((aryl)amino)-1,3,5-triazin-2-ylamino)-N-(pyrimidin-2-yl) benzenesulfonamides. J. Saudi Chem. Soc., 2017, 21, S25-S34.
[http://dx.doi.org/10.1016/j.jscs.2013.09.006]
[86]
Desai, S.D.; Mehta, A.G. Design, synthesis, characterization and biological evaluation of various N-substituted piperazine annulated s-triazine derivatives. Res. J. Chem. Sci., 2014, 4(5), 14-19.
[87]
Parikh, K.S.; Vyas, S.P. Design, characterization and biological activity of a new series of s-triazines derived with morpholine. J. Appl. Pharm. Sci., 2012, 02(05), 111-114.
[http://dx.doi.org/10.7324/JAPS.2012.2519]
[88]
Desai, N.C.; Makwana, A.H.; Rajpara, K.M. Synthesis and study of 1,3,5-triazine based thiazole derivatives as antimicrobial agents. J. Saudi Chem. Soc., 2016, 20, S334-S341.
[http://dx.doi.org/10.1016/j.jscs.2012.12.004]
[89]
Mewada, N.S.; Shah, D.R.; Lakum, H.P.; Chikhalia, K.H. Synthesis and biological evaluation of novel s-triazine based aryl/heteroaryl entities: Design, rationale and comparative study. J. Assoc. Arab Univ. Basic Appl. Sci., 2016, 20, 8-18.
[http://dx.doi.org/10.1016/j.jaubas.2014.08.003]
[90]
Hamama, W.S.; El-Bana, G.G.; Shaaban, S.; Zoorob, H.H. Synthetic approach to some new annulated 1,2,4-triazine skeletons with antimicrobial and cytotoxic activities. J. Heterocycl. Chem., 2018, 55(4), 971-982.
[http://dx.doi.org/10.1002/jhet.3127]
[91]
Hamama, W.S.; El-Bana, G.G.; Mostafa, M.E.; Zoorob, H.H. Synthesis and acaricidal activity of some new 1,2,4-triazine derivatives. J. Heterocycl. Chem., 2019, 56, 239.
[http://dx.doi.org/10.1002/jhet.3401]
[92]
Kaur, B.; Kaur, A.; Kuletha, S.; Sinha, M.; Singh, K.; Bhatia, R. Anticancer activity of aminoacid linked novel 4-methylumbelliferone derivatives. Curr. Bioact. Compd., 2019, 15(1), 51-62.
[http://dx.doi.org/10.2174/1573407213666170210143503]
[93]
Issartel, V.; Spehner, V.; Coudert, P.; Seilles, E.; Couquelet, J. Synthesis of new pyrrolo[1,2-d][1,2,4]triazines and thiazolo[3,4-d][1,2,4]triazines as immunostimulating agents. Bioorg. Med. Chem., 1998, 6(3), 349-354.
[http://dx.doi.org/10.1016/S0968-0896(97)10052-9] [PMID: 9568288]
[94]
Brzozowski, Z.; Saczewski, F.; Gdaniec, M. Synthesis, structural characterization and antitumor activity of novel 2,4-diamino-1,3,5-triazine derivatives. Eur. J. Med. Chem., 2000, 35(12), 1053-1064.
[http://dx.doi.org/10.1016/S0223-5234(00)01194-6] [PMID: 11248404]
[95]
Brzozowski, Z.; Saczewski, F. Synthesis and antitumor activity of novel 2-amino-4-(3,5,5-trimethyl-2-pyrazolino)-1,3,5-triazine derivatives. Eur. J. Med. Chem., 2002, 37(9), 709-720.
[http://dx.doi.org/10.1016/S0223-5234(02)01379-X] [PMID: 12350288]
[96]
Diana, P.; Barraja, P.; Lauria, A.; Montalbano, A.; Almerico, A.M.; Dattolo, G.; Cirrincione, G. Pyrrolo[2,1-c][1,2,4]triazines from 2-diazopyrroles: synthesis and antiproliferative activity. Eur. J. Med. Chem., 2002, 37(3), 267-272.
[http://dx.doi.org/10.1016/S0223-5234(02)01339-9] [PMID: 11900871]
[97]
Lakomska, I.; Golankiewicz, B.; Wietrzyk, J.; Pelczynska, M.; Nasulewicz, A.; Opolski, A.; Sitkowski, J.; Kozerski, L.; Szlyk, E. Synthesis, spectroscopial characterization and the biological activity in vitro of new platinum (II) complexes with imidazo[1,5-a]-1,3,5-triazine derivatives and dimethylsulfoxide. Inorg. Chim. Acta, 2005, 358(6), 1911-1917.
[http://dx.doi.org/10.1016/j.ica.2004.12.033]
[98]
Dalloul, H.M.; Mohamed, E.H.A.R.; Shorafa, H.Z.; El-Shorafa, A.Z. Heterocyclic synthesis using nitrilimines. Part 11. Synthesis of 1-aryl-3-phenylaminocarbonyl-4,5-dihydro-1,4,5-triazin-6-ones. ARKIVOC, 2008, 13, 207-217.
[99]
Mojzych, M. Cytotoxic activity of some pyrazolo[4,3-e][1,2,4]triazines against human cancer cell lines. J. Chem. Soc. Pak., 2011, 33(1), 123-128.
[100]
Ünsalan, S.; Çıkla, P.; Küçükgüzel, S.G.; Rollas, S.; Şahin, F.; Bayrak, O.F. Synthesis and characterization of triazenes derived from sulfonamides. Marmara Pharm. J., 2011, 15(2), 11-17.
[http://dx.doi.org/10.12991/201115439]
[101]
Abdel-Sayed, W.; Nassar, I.F.; Abdel-Rahman, A.A.H. Synthesis and antitumor activity of new 1,2,4-triazine and [1,2,4]triazolo[4,3-b][1,2,4]triazine derivatives and their thioglycoside and acyclic C-nucleoside analogs. J. Heterocycl. Chem., 2011, 48(1), 135-143.
[http://dx.doi.org/10.1002/jhet.522]
[102]
Gibson, N.W.; Erickson, L.C.; Hickman, J.A. Effects of the antitumor agent 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one on the DNA of mouse L1210 cells. Cancer Res., 1984, 44(5), 1767-1771.
[PMID: 6713380]
[103]
Hodous, B.L.; Geuns-Meyer, S.D.; Hughes, P.E.; Albrecht, B.K.; Bellon, S.; Bready, J.; Caenepeel, S.; Cee, V.J.; Chaffee, S.C.; Coxon, A.; Emery, M.; Fretland, J.; Gallant, P.; Gu, Y.; Hoffman, D.; Johnson, R.E.; Kendall, R.; Kim, J.L.; Long, A.M.; Morrison, M.; Olivieri, P.R.; Patel, V.F.; Polverino, A.; Rose, P.; Tempest, P.; Wang, L.; Whittington, D.A.; Zhao, H. Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor. J. Med. Chem., 2007, 50(4), 611-626.
[http://dx.doi.org/10.1021/jm061107l] [PMID: 17253678]
[104]
Gucký, T.; Frysová, I.; Slouka, J.; Hajdúch, M.; Dzubák, P. Cyclocondensation reaction of heterocyclic carbonyl compounds. Part XIII: Synthesis and cytotoxic activity of some 3,7-diaryl-5-(3,4,5-trimethoxyphenyl)pyrazolo[4,3-e][1,2,4]triazines. Eur. J. Med. Chem., 2009, 44(2), 891-900.
[http://dx.doi.org/10.1016/j.ejmech.2008.05.026] [PMID: 18632190]
[105]
Manohar, S.; Khan, S.I.; Rawat, D.S. Synthesis, antimalarial activity and cytotoxicity of 4-aminoquinoline-triazine conjugates. Bioorg. Med. Chem. Lett., 2010, 20(1), 322-325.
[http://dx.doi.org/10.1016/j.bmcl.2009.10.106] [PMID: 19910192]
[106]
Mohareb, R.M.; Samir, E.M. The reaction of cyanoacetylhydrazine with chloroacetone: Synthesis of 1,2,4-triazine, 1,3,4-oxadiazine and their fused derivatives with antitumor activities. Open J. Med. Chem., 2012, 2, 1-9.
[http://dx.doi.org/10.4236/ojmc.2012.21001]
[107]
Abd El-All, A.S.; Hassan, A.S.; Osman, S.A.; Yosef, H.A.A.; Abdel-Hady, W.H.; El-Hashash, M.A.; Atta-Allah, S.R.; Ali, M.M.; El Rashedy, A.A. Synthesis, characterization and biological evaluation of new fused triazine derivatives based on 6-methyl-3-thioxo-1,2,4-triazin-5-one. Acta Pol. Pharm., 2016, 73(1), 79-92.
[PMID: 27008803]
[108]
Manohar, S.; Pepe, A.; Gerena, C.E.V.; Zayas, B.; Malhotra, S.V.; Rawat, D.S. Anticancer activity of 4-aminoquinoline-triazine based molecular hybrids. RSC Advances, 2014, 4, 7062.
[http://dx.doi.org/10.1039/c3ra45333b]
[109]
Srivastava, J.K.; Pillai, G.G.; Bhat, H.R.; Verma, A.; Singh, U.P. Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase. Sci. Rep., 2017, 7(1), 5851.
[http://dx.doi.org/10.1038/s41598-017-05934-5] [PMID: 28724908]
[110]
Patel, A.B.; Chikhalia, K.H.; Kumari, P. An efficient synthesis of new thiazolidin-4-one fused s-triazines as potential antimicrobial and anticancer agents. J. Saudi Chem. Soc., 2014, 18, 646-656.
[http://dx.doi.org/10.1016/j.jscs.2014.02.002]
[111]
Fu, D.J.; Song, J.; Hou, Y.H.; Zhao, R.H.; Li, J.H.; Mao, R.W.; Yang, J.J.; Li, P.; Zi, X.L.; Li, Z.H.; Zhang, Q.Q.; Wang, F.Y.; Zhang, S.Y.; Zhang, Y.B.; Liu, H.M. Discovery of 5,6-diaryl-1,2,4-triazines hybrids as potential apoptosis inducers. Eur. J. Med. Chem., 2017, 138, 1076-1088.
[http://dx.doi.org/10.1016/j.ejmech.2017.07.011] [PMID: 28763643]
[112]
Aly, M.R.E.; Gobouri, A.A.; Abdel Hafez, S.H.; Saad, H.A. Synthesis, reactions, and biological activity of some triazine derivatives containing sulfa drug moieties. Bioorg. Khim., 2015, 41(4), 491-504.
[http://dx.doi.org/10.7868/S013234231504003X] [PMID: 26615645]
[113]
Lauria, A.; Alfio, A.; Bonsignore, R.; Gentile, C.; Martorana, A.; Gennaro, G.; Barone, G.; Terenzi, A.; Almerico, A.M. New benzothieno[3,2-d]-1,2,3-triazines with antiproliferative activity: Synthesis, spectroscopic studies, and biological activity. Bioorg. Med. Chem. Lett., 2014, 24(15), 3291-3297.
[http://dx.doi.org/10.1016/j.bmcl.2014.06.007] [PMID: 24986661]
[114]
Saad, H.A.; Youssef, M.M.; Mosselhi, M.A. Microwave assisted synthesis of some new fused 1,2,4-triazines bearing thiophene moieties with expected pharmacological activity. Molecules, 2011, 16(6), 4937-4957.
[http://dx.doi.org/10.3390/molecules16064937] [PMID: 21677606]
[115]
Moreno, L.M.; Quiroga, J.; Abonia, R.; Ramírez-Prada, J.; Insuasty, B. Synthesis of new 1,3,5-triazine-based 2-pyrazolines as potential anticancer agents. Molecules, 2018, 23(8), 1956.
[http://dx.doi.org/10.3390/molecules23081956] [PMID: 30082588]
[116]
Abou-Elregal, M.K.; Mohamed, A.T.A.; Youssef, A.S.A.; Hemdan, M.M.; Samir, S.S.; Abou-Elmagd, W.S.I. Synthesis and antitumor activity evaluation of some 1, 2, 4-triazine and fused triazine derivatives. Synth. Commun., 2018, 48(18), 2347-2357.
[http://dx.doi.org/10.1080/00397911.2018.1482350]
[117]
Shi, W.; Qiang, H.; Huang, D.; Bi, X.; Huang, W.; Qian, H. Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2. Eur. J. Med. Chem., 2018, 158, 814-831.
[http://dx.doi.org/10.1016/j.ejmech.2018.09.050] [PMID: 30248654]
[118]
Schunk, M.; Jelinek, T.; Wetzel, K.; Nothdurft, H.D. Detection of Giardia lamblia and Entamoeba histolytica in stool samples by two enzyme immunoassays. Eur. J. Clin. Microbiol. Infect. Dis., 2001, 20(6), 389-391.
[http://dx.doi.org/10.1007/PL00011279] [PMID: 11476438]
[119]
World Health Organization Intestinal Parasites. 2000.
[120]
Abdullah, I.; Tak, H.; Ahmad, F.; Gul, N.; Nabi, S.; Sofi, T.A. Predominance of gastrointestinal protozoan parasites in children: A brief review. J. Health Educ. Res. Dev., 2016, 4(4), 194.
[http://dx.doi.org/10.4172/2380-5439.1000194]
[121]
Kondaparla, S.; Debnath, U.; Soni, A.; Dola, V.R.; Sinha, M.; Srivastava, K.; Puri, S.K.; Katti, S.B. Synthesis, biological evaluation and molecular modeling studies of chiral chloroquine analogues as antimalarial agents. Antimicrob. Agents Chemother., 2018, 62(12), e02347-e17.
[http://dx.doi.org/10.1128/AAC.02347-17] [PMID: 30224532]
[122]
Greif, G. Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans. U.S. Patent 20,090,181,040, July 16, 2009.
[123]
Ponazuril. http://en.wikipedia.org/wiki/Ponazuril2011. (Accessed February 7, 2011)
[124]
Stock, M.L.; Elazab, S.T.; Hsu, W.H. Review of triazine antiprotozoal drugs used in veterinary medicine. J. Vet. Pharmacol. Ther., 2018, 41(2), 184-194.
[http://dx.doi.org/10.1111/jvp.12450]
[125]
Agarwal, A.; Srivastava, K.; Puri, S.K.; Chauhan, P.M.S. Syntheses of 2,4,6-trisubstituted triazines as antimalarial agents. Bioorg. Med. Chem. Lett., 2005, 15(3), 531-533.
[http://dx.doi.org/10.1016/j.bmcl.2004.11.052] [PMID: 15664807]
[126]
Katiyar, S.B.; Srivastava, K.; Puri, S.K.; Chauhan, P.M.S. Synthesis of 2-[3,5-substituted pyrazol-1-yl]-4,6-trisubstituted triazine derivatives as antimalarial agents. Bioorg. Med. Chem. Lett., 2005, 15(22), 4957-4960.
[http://dx.doi.org/10.1016/j.bmcl.2005.08.023] [PMID: 16168643]
[127]
Bhat, H.R.; Singh, U.P.; Gahtori, P.; Ghosh, S.K.; Gogoi, K.; Prakash, A.; Singh, R.K. Synthesis, docking, in vitro and in vivo antimalarial activity of hybrid 4-aminoquinoline-1,3,5-triazine derivatives against wild and mutant malaria parasites. Chem. Biol. Drug Des., 2015, 86(3), 265-271.
[http://dx.doi.org/10.1111/cbdd.12490] [PMID: 25487527]
[128]
Bhat, H.R.; Singh, U.P.; Thakur, A.; Ghosh, S.K.; Gogoi, K.; Prakash, A.; Singh, R.K. Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives. Experiment.Parasitol., 2015, 157, 59-67.
[http://dx.doi.org/10.1016/j.exppara.2015.06.016]
[129]
Bhat, H.R.; Singh, U.P.; Yadav, P.S.; Kumar, V.; Gahtori, P.; Das, A.; Chetia, D.; Prakash, A.; Mahanta, J. Synthesis, characterization and antimalarial activity of hybrid 4-aminoquinoline-1,3,5-triazine derivatives. Arab. J. Chem., 2016, 9, S625-S631.
[http://dx.doi.org/10.1016/j.arabjc.2011.07.001]
[130]
Kalita, J.M.; Ghosh, S.K.; Sahu, S.; Dutta, M. Rational design and microwave assisted synthesis of some novel phenyl thiazolyl clubbed s-triazine derivatives as antimalarial antifolate. Future J. Pharm. Sci., 2017, 3, 11-17.
[http://dx.doi.org/10.1016/j.fjps.2016.09.004] [PMID: 27880887]
[131]
Shandilya, A.; Hoda, N.; Khan, S.; Jameel, E.; Kumar, J.; Jayaram, B. De novo lead optimization of triazine derivatives identifies potent antimalarials. J. Mol. Graph. Model., 2017, 71, 96-103.
[http://dx.doi.org/10.1016/j.jmgm.2016.10.022] [PMID: 27880887]
[132]
Sahu, S.; Ghosh, S.K.; Kalita, J.; Dutta, M.; Bhat, H.R. Design, synthesis and antimalarial screening of some hybrid 4-aminoquinoline-triazine derivatives against pf-DHFR-TS. Exp. Parasitol., 2016, 163, 38-45.
[http://dx.doi.org/10.1016/j.exppara.2016.01.010] [PMID: 26821296]
[133]
Kumar, D.; Khan, S.I.; Ponnana, P.; Rawat, D.S. Triazine-pyrimidine based molecular hybrids: synthesis, docking studies and evaluation of antimalarial activity. New J. Chem., 2014, 38, 5087-5095.
[http://dx.doi.org/10.1039/C4NJ00978A]
[134]
Sharma, M.; Chauhan, K.; Chauhan, S.S.; Kumar, A.; Singh, S.V.; Saxena, J.K.; Agarwal, P.; Srivastava, K.; Kumar, S.R.; Puri, S.K.; Shah, P.; Siddiqid, M.I.; Chauhan, P.M.S. Synthesis of hybrid 4-anilinoquinoline triazines as potent antimalarial agents, their in-silico modeling and bioevaluation as Plasmodium falciparum transketolase and b-hematin inhibitors. MedChemComm, 2012, 3, 71.
[http://dx.doi.org/10.1039/C1MD00188D]
[135]
Wu, P.; Yongzhou, H. Small molecules targeting phosphoinositide 3-kinases. MedChemComm, 2012, 3, 1337-1355.
[http://dx.doi.org/10.1039/c2md20044a]
[136]
Falasca, M.; Maffucci, T. Role of class II phosphoinositide 3-kinase in cell signalling. Biochem. Soc. Trans., 2007, 35(Pt 2), 211-214.
[http://dx.doi.org/10.1042/BST0350211] [PMID: 17371240]
[137]
Kong, D.; Okamura, M.; Yoshimi, H.; Yamori, T. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor. Eur. J. Cancer, 2009, 45(5), 857-865.
[http://dx.doi.org/10.1016/j.ejca.2008.12.007] [PMID: 19144509]
[138]
Liu, B.; Sun, T.; Zhou, Z.; Du, L. A systematic review on antitumor agents with 1, 3, 5-triazines. Med. Chem., 2015, 5(3), 131-148.
[http://dx.doi.org/10.4172/2161-0444.100]

Rights & Permissions Print Cite
Article Metrics
49
1
© 2024 Bentham Science Publishers | Privacy Policy